Brad Prosek has been in the biotechnology business for over 25 years. Most recently, he served as Senior Vice President and Chief Business Officer at Constellation Pharmaceuticals, an oncology-focused biotech company that was acquired by MorphoSys AG in July 2021. Brad’s experience spans corporate development, strategy and commercial roles in the US and Europe. In addition to Constellation, Brad contributed to building Cubist Pharmaceuticals, Biogen, and Covance Market Access Services. Brad holds an M.B.A. from Columbia University and a B.S.F.S. from Georgetown University with a concentration in Science & Technology.
Finnegan Oskar Prosek
Finnegan Oskar Prosek was born outside Boston, Massachusetts in 2021. He’s an Australian Cobberdog, which is really just a fancy name for a Labradoodle. He doesn’t bark, but rather just shouts “Oi!, Oi!” when someone new comes to the door. He’s mostly learned his manners, and spends his days delighting the rest of the Prosek family with high-speed outdoor runs and big doggie yoga stretches.